The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age–Period–Cohort Analysis

This study aims to report the most up-to-date information about the global disease burden of glaucoma from 1990 to 2019 and to forecast trends in the next few years. Publicly available data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 were used in this study. The prevalence and disability-adjusted life years (DALYs) of glaucoma from 1990 to 2019 were reported. Finally, trends in the years following 2019 were predicted by Bayesian age–period–cohort (BAPC) models. We showed that, globally, the number of prevalent cases was 3,881,624 [95% uncertainty interval (UI): 3,301,963 to 4,535,045] in 1990 and increased to 7,473,400 (95% UI: 6,347,183 to 8,769,520) in 2019, while the age-standardized prevalence rate decreased from 111.92 [95% uncertainty interval (UI): 94.76 to 130.28 per 100,000] in 1990 to 94.68 (95% UI: 80.42 to 110.87 per 100,000) in 2019. The DALY number of glaucoma increased between 1990 and 2019, from 442,182 (95% UI: 301,827 to 626,486) in 1990 to 748,308 (95% UI: 515,636 to 1,044,667) in 2019. There was a significantly negative association between the sociodemographic index (SDI) and age-standardized DALY rates. The BAPC showed that the age-standardized DALY rate is predicted to decrease gradually in both males and females over the next few years. In summary, from 1990 to 2019, the global burden of glaucoma increased and the age-standardized DALY rate is predicted to decrease in the next few years. With the largest burden of glaucoma found in low-SDI regions, clinical diagnosis and treatment in such areas are more challenging and may warrant more attention.

[1]  Guangming Jin,et al.  Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study , 2022, Clinical epidemiology.

[2]  N. Congdon,et al.  Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017 , 2022, BMJ Open.

[3]  T. Vos,et al.  The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019 , 2021, The lancet. Psychiatry.

[4]  J. Stein,et al.  Glaucoma in Adults-Screening, Diagnosis, and Management: A Review. , 2021, JAMA.

[5]  Zhebin Du,et al.  Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study , 2020, Biomarker Research.

[6]  Jiayue Zhou,et al.  Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016 , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  Min Fan,et al.  Time trends and heterogeneity in the disease burden of glaucoma, 1990-2017: a global analysis , 2019, Journal of global health.

[8]  Wenyong Huang,et al.  Epidemiological variations and trends in health burden of glaucoma worldwide , 2019, Acta ophthalmologica.

[9]  S. Ehl,et al.  The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data , 2018, Orphanet Journal of Rare Diseases.

[10]  Brian C. Stagg,et al.  A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery , 2018, JAMA ophthalmology.

[11]  I. Rudan,et al.  National and subnational prevalence and burden of glaucoma in China: A systematic analysis , 2017, Journal of global health.

[12]  R. Ritch,et al.  Glaucoma , 2017, The Lancet.

[13]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[14]  Leonhard Held,et al.  Projecting the future burden of cancer: Bayesian age–period–cohort analysis with integrated nested Laplace approximations , 2017, Biometrical journal. Biometrische Zeitschrift.

[15]  Nobhojit Roy,et al.  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition , 2015, The Lancet.

[16]  T. Wong,et al.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. , 2014, Ophthalmology.

[17]  H. Taylor,et al.  Prevalence and causes of vision loss in East Asia: 1990–2010 , 2014, British Journal of Ophthalmology.

[18]  Paul P. Lee,et al.  An assessment of the health and economic burdens of glaucoma. , 2011, American journal of ophthalmology.